Individuals with heart failure (HF) have a high burden of health care utilization, costs, and morbidity in the year following hospitalization for an acute HF exacerbation. Frailty, which has been described as increased vulnerability to adverse events, is common among those with HF and increases with age [1]. Health systems worldwide are integrating automated tools within electronic health records to measure frailty. However, using longitudinal data to measure frailty and better predict outcomes among those with HF has rarely been considered [2-5]. We sought to evaluate the predictive value of adding longitudinal data to a standard frailty index (FI) and evaluate predictions of 1-year outcomes in patients with HF.

In total, 54,774 veterans were included (age: mean 73.3, SD 10.1 y; BMI: mean 30.1, SD 7.5 kg/m²; male: n=53,899, 98.4%; White: n=30,406, 55.5%; Table 1). Figure 1 shows the AUC_FI and AUC_FT+FI across the distribution of frailty ranges, from prefrail (FI: 0.1-0.2) to frail; an FI of 0.2 is equivalent to an accumulation of 7 deficits among 31 variables, and the Δ_AUC is also displayed. For all veterans across all FI thresholds, the AUC improved by at least 4.1% when adding the FT to the FI. The highest Δ_AUC (24%) was observed for FIs of 0.13 to 0.16, and it decreased to ≤10% for FIs of ≥0.2.

In a national cohort of veterans who were admitted to the VA for HF, the addition of longitudinal FT data resulted in a clinically significant (up to 24%) improvement in 1-year mortality prediction when compared to a standard FI alone among patients in the prefrail range. In contrast, we observed a modest (at least 4.1%) improvement in 1-year mortality prediction in the overall population. Enhancing AUC prediction for patients in the prefrail range is clinically important, as interventions that mitigate frailty may be most impactful in this population [7]. Patients with prefrailty may benefit from interventions (eg, cardiac rehabilitation) that improve frailty status and cardiovascular outcomes [1]. These findings enrich our understanding of the importance of FT in patients at lower FI levels, and a previous study compared the importance of FIs to that of FTs alone [5]. These results may not generalize to nonveteran populations. The sample was predominately male but did include a diverse population in terms of race, ethnicity, and geographic distribution. In summary, methods for calculating frailty provide useful predictions of adverse outcomes among adults with HF. The addition of longitudinal frailty data improves predictions for patients with HF and prefrailty. These findings aid clinician and health system decision-making, as this population benefits most from interventions that slow or prevent frailty progression, and suggest that longitudinal data for modeling FT provide additional evidence for tailoring interventions to patients with HF who may benefit most from tailored interventions.